Consequences Of Biomarker Analysis On The Cost-Effectiveness Of Cetuximab In Combination With Irinotecan Based Chemotherapy For First-Line Treatment Of Metastatic Colorectal Cancer. Stratified Medicine At Work?
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1165
https://www.valueinhealthjournal.com/article/S1098-3015(15)03241-6/fulltext
Title :
Consequences Of Biomarker Analysis On The Cost-Effectiveness Of Cetuximab In Combination With Irinotecan Based Chemotherapy For First-Line Treatment Of Metastatic Colorectal Cancer. Stratified Medicine At Work?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03241-6&doi=10.1016/j.jval.2015.09.1165
First page :
A456
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
668